Silverman Lou's Form 4 filing
Staar Surgical Co (STAA) · filed Aug 12, 2021
- Accession no.
- 0001209191-21-051095
- Filed
- Aug 12, 2021
- Trade date
- Aug 10, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $4.36M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Silverman LouCIK 0001249935 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | MOption exerciseAcquired | +10,000 | $9.31 | +$93,100 | 12,924 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −10,000 | $145.57F1 | −$1,455,700 | 2,924 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseAcquired | +10,000 | $8.35 | +$83,500 | 12,924 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −10,000 | $145.56F2 | −$1,455,600 | 2,924 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseAcquired | +9,921 | $9.60 | +$95,241.6 | 12,845 | Direct | |
| Aug 10, 2021 | Common Stock | SSaleDisposed | −9,921 | $145.54F3 | −$1,443,902.34 | 2,924 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −10,000 | $0.00 | $0 | 0 | Direct | |
| Aug 10, 2021 | Common Stock | MOption exerciseDisposed | −9,921 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.96 to $153.68, inclusive.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.98 to $153.68, inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.00 to $153.68, inclusive.
Referenced by the price of 1 transaction in Table I.
Remarks
This Form 4 reflects a sale by Mr. Silverman of Common Stock of the Company pursuant to instructions contained in a pre-established Rule 10b5-1 plan.